Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

NCT05411887 · tracked via the Priya Life Science South Korea tracker

Sponsor

Daewoong Pharmaceutical Co. LTD

Phase

Observational

Started

2022-06-20

Last updated

2025-08-24

Condition(s) studied

HyperlipidemiasHypertension

Investigational drug(s) / intervention(s)

Rosuvastatin, Olmesartan Medoxomil

Rosuvastatin, Olmesartan Medoxomil: Olostar Tablet

Study summary

The purpose of this study is to evaluate the effectiveness of Olostar Tablet on blood pressure and lipid profiles, obtain safety-related information for subgroups that failed to participate in the clinical trials, and to evaluate variables that affect treatment effectiveness.

Eligibility

Sex

ALL

Min age

19 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. men and women over the age of 19 2. Patients who signed a written consent form to participate in the study 3. Patients who are eligible for Olostar tablet prescription according to domestic permission Exclusion Criteria: 1. A person who falls under "2. Do not administer to the following patients" among the precautions for use in the user manual 2. Patients in hospital (hospitals only; nursing care facilities can be recruited) 3. A person who has been administered the study target drug or is being administered at the time of recruitment within 6 months based on the date of the study contract

Primary outcome measure(s)

absolute change and rate of change in low-density lipoprotein cholesterol (LDL-C) — 24 weeks
Evaluation of absolute change and rate of change in low-density lipoprotein cholesterol (LDL-C) compared to baseline
absolute change and rate of change in systolic and diastolic blood pressure — 24 weeks
Evaluation of absolute change and rate of change in systolic and diastolic blood pressure compared to baseline

Trial sites (1)

Facility	City	Region	Status
Severance Hospital	Seoul	South Korea

More Daewoong Pharmaceutical Co. LTD. trials in South Korea

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF Active, not recruiting

Noseguard for Prevention of Respiratory Infections in Real-World Use Starting soon

Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension Recruiting

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients Starting soon

Other trials for the same condition

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B Active, not recruiting

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers Recruiting

The Effect of Home Blood Pressure Measurement on the Management of Hypertension Active, not recruiting

Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor Recruiting

To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05411887 on ClinicalTrials.gov ↗ ← All trials in South Korea